Johnson & Johnson (JNJ)

Cash ratio

Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Cash and cash equivalents US$ in thousands 18,231,000 18,577,000 38,474,000 24,105,000 19,980,000 24,878,000 25,473,000 21,859,000 19,728,000 21,183,000 19,170,000 12,889,000 11,355,000 10,983,000 10,463,000 14,487,000 17,604,000 14,332,000 12,671,000 13,985,000
Short-term investments US$ in thousands 331,000 303,000 307,000 417,000 317,000 597,000 745,000 1,068,000 3,783,000 7,322,000 5,443,000 9,392,000 22,724,000 21,585,000 19,925,000 17,121,000 13,397,000 10,974,000 11,948,000 11,200,000
Total current liabilities US$ in thousands 50,869,000 54,180,000 56,903,000 50,321,000 51,759,000 53,933,000 48,725,000 46,282,000 44,370,000 54,170,000 60,373,000 55,802,000 45,543,000 44,821,000 43,390,000 45,226,000 44,561,000 38,721,000 40,932,000 42,493,000
Cash ratio 0.36 0.35 0.68 0.49 0.39 0.47 0.54 0.50 0.53 0.53 0.41 0.40 0.75 0.73 0.70 0.70 0.70 0.65 0.60 0.59

September 30, 2025 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($18,231,000K + $331,000K) ÷ $50,869,000K
= 0.36


See also:

Johnson & Johnson Cash Ratio (Quarterly Data)